Harleysville, PA, United States of America

Richard William Connors

USPTO Granted Patents = 5 



Average Co-Inventor Count = 9.6

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2007-2012

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations of Richard William Connors

Introduction

Richard William Connors is a notable inventor based in Harleysville, Pennsylvania. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target protein tyrosine kinases. With a total of five patents to his name, Connors has established himself as a key figure in the innovation of therapeutic agents.

Latest Patents

Connors' latest patents include groundbreaking work on triazolopyridazine compounds. These inventions are directed towards compounds of Formula I, where specific groups are defined for their use as protein tyrosine kinase modulators. Notably, these compounds serve as inhibitors of c-Met, a critical target in cancer therapy. The inventions detail methods for reducing or inhibiting the kinase activity of c-Met in cells or subjects, as well as modulating c-Met expression. Furthermore, these compounds are aimed at preventing or treating cell proliferative disorders, including various cancers. The patents also encompass pharmaceutical compositions that utilize these compounds for therapeutic applications.

Career Highlights

Richard William Connors is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work focuses on the development of innovative treatments that address significant health challenges. Connors' expertise in the field has led to advancements that may improve patient outcomes in the treatment of cancer and related disorders.

Collaborations

Some of Connors' notable coworkers include Dana L Johnson and Tianbao Lu. Their collaborative efforts contribute to the innovative research and development initiatives at Janssen Pharmaceutica NV.

Conclusion

Richard William Connors exemplifies the spirit of innovation in the pharmaceutical industry through his patents and contributions to cancer treatment. His work continues to pave the way for new therapeutic options that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…